Thermo Fisher Scientific Inc. (TMO): Marc N Casper , Chief Executive Officer of Thermo Fisher Scientific Inc. sold 20,000 shares on Jul 5, 2016. The Insider selling transaction was reported by the company on Jul 7, 2016 to the Securities and Exchange Commission. The shares were sold at $147.95 per share for a total value of $2,953,804.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 6, 2016, Marc N Casper (Chief Executive Officer) sold 30,000 shares at $148.70 per share price.On Jun 16, 2016, Daniel P Shine (Senior Vice President) sold 6,900 shares at $148.34 per share price.Also, On Jun 14, 2016, Peter M Wilver (Exec. VP & Chief Admin Officer) sold 68,200 shares at $152.49 per share price.On Jun 6, 2016, Jim P Manzi (director) sold 1,137 shares at $153.00 per share price.
Shares of Thermo Fisher Scientific (TMO) ended Tuesday, Jul 6, 2016 session in red amid volatile trading. The shares closed down -1.98 points or -1.33% at $147.25 with 18,78,161 shares getting traded. Post opening the session at $148.2, the shares hit an intraday low of $146.64 and an intraday high of $148.74 and the price vacillated in this range throughout the day. The company has a market cap of $57,945 M and the number of outstanding shares has been calculated to be 39,35,12,230 shares. The 52-week high of Thermo Fisher Scientific is $154.81 and the 52-week low is $117.1.
Company has been under the radar of several Street Analysts.Thermo Fisher Scientific is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 170 from a previous price target of $166 .The Rating was issued on May 27, 2016.Thermo Fisher Scientific is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 166 from a previous price target of $163 .The Rating was issued on May 19, 2016.Thermo Fisher Scientific is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 163 from a previous price target of $160 .The Rating was issued on May 3, 2016.Thermo Fisher Scientific is Downgraded by Jefferies to Hold. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Apr 29, 2016.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.